{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06497088",
            "orgStudyIdInfo": {
                "id": "NST-DHF-076"
            },
            "organization": {
                "fullName": "Nasotrak Medical Pte Ltd",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Clinical Study to Evaluate the Ultrasonic Detection of a Novel Nasogastric Tube in the Human Body.",
            "officialTitle": "A Clinical Study to Evaluate the Ultrasonic Detection of a Novel Nasogastric Tube in the Human Body",
            "study": "a-clinical-study-to-evaluate-the-ultrasonic-detection-of-a-novel-nasogastric-tube-in-the-human-body"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-08-01",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-06-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-06-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-07-04",
            "studyFirstSubmitQcDate": "2024-07-04",
            "studyFirstPostDateStruct": {
                "date": "2024-07-11",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-22",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-24",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Nasotrak Medical Pte Ltd",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true,
            "isUnapprovedDevice": true,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to evaluate the safety, efficacy and accuracy of the Nasotrak System in an adult patient population."
        },
        "conditionsModule": {
            "conditions": [
                "Nasogastric Tube Placement"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "OTHER",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 90,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Nasotrak System",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Device: Nasotrak System"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "Nasotrak System",
                    "description": "Device: The Nasotrak System\n\nThe Nasotrak Medical System is intended to aid, in conjunction with institutional protocols, qualified operators in the placement of the Nasotrak's 12 Fr feeding tube into the stomach of patients requiring enteral feeding after insertion and before every feed. The Nasotrak nasogastric tube(NGT) is designed for use with Nasotrak's handheld device (HHD) which is able to detect the tip of the NGT via piezoelectric sensor, which converts ultrasound waves to electronic signals, thus assisting to track its location as an indicator of placement in the stomach. Nasotrak's NGT is intended only to be used with Nasotrak's HHD.\n\nThe Nasotrak NGT is intended for the administration of nutrition, fluids and medications by the nasoenteric route for patients who have an intact gastrointestinal tract but are physically unable to manage nutritional intake through normal mastication and deglutition.",
                    "armGroupLabels": [
                        "Nasotrak System"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Evaluate the effectiveness of detecting Nasotrak's nasogastric tube's distal tip using Nasotrak's ultrasound verification algorithm compared to X-ray.",
                    "description": "All patients will receive placement verification per institutional practice",
                    "timeFrame": "1 year"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Adults greater than 18 years of age\n* Able to provide informed consent or have a legally authorized representative available to provide informed consent in English\n* Clinically requiring a 12 Fr NG/OG tube with X-ray confirmation per standard protocol\n\nExclusion Criteria:\n\n* Female subjects of childbearing age with known pregnancy or lactating.\n* Prisoners.\n* Unable to consent in English.\n* Subjects/ volunteers with pacemakers or life-sustaining devices in the body such as ICD.\n* Subjects with a history of:\n* Esophageal varices or ulcers.\n* Upper airway obstruction.\n* Upper GI stenosis or obstruction.\n* Trauma involving sinuses, nares face or neck that would prevent nasogastric (NG) or oral tube insertion.\n* Deformities of the sinus cavities and/or skull base.\n* Esophageal cancer or neoplasm.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "David Tan",
                    "role": "CONTACT",
                    "phone": "+65 6461 7016",
                    "email": "david@nasotrak.com.sg"
                }
            ],
            "overallOfficials": [
                {
                    "name": "David Tan, Beng",
                    "affiliation": "Nasotrak Medical Pte Ltd",
                    "role": "STUDY_CHAIR"
                }
            ],
            "locations": [
                {
                    "facility": "Parkview Regional Medical Center",
                    "city": "Fort Wayne",
                    "state": "Indiana",
                    "zip": "46845",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jan Powers, PhD",
                            "role": "CONTACT",
                            "phone": "260-266-7761",
                            "email": "jan.powers@parkview.com"
                        },
                        {
                            "name": "Jan Powers, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.1306,
                        "lon": -85.12886
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        }
    },
    "hasResults": false
}